Karpenko LI - Search Results

1

Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate.

Karpenko LI, Rudometov AP, Sharabrin SV, Shcherbakov DN, Borgoyakova MB, Bazhan SI, Volosnikova EA, Rudometova NB, Orlova LA, Pyshnaya IA, Zaitsev BN, Volkova NV, Azaev MS, Zaykovskaya AV, Pyankov OV, Ilyichev AA. Karpenko LI, et al. Vaccines (Basel). 2021 Jan 21;9(2):76. doi: 10.3390/vaccines9020076. Vaccines (Basel). 2021. PMID: 33494530 Free PMC article.

2

Mutagenic properties of oligonucleotides with modified sugar-phosphate backbone.

Petrenko VA, Kuzmicheva GA, Tatkov SI, Karpenko LI, Ilyichev AA. Petrenko VA, et al. Among authors: karpenko li. Nucleic Acids Symp Ser. 1991;(24):213-4. Nucleic Acids Symp Ser. 1991. PMID: 1841288 No abstract available.

3

Design of immunogens as components of a new generation of molecular vaccines.

Loktev VB, Ilyichev AA, Eroshkin AM, Karpenko LI, Pokrovsky AG, Pereboev AV, Svyatchenko VA, Ignat'ev GM, Smolina MI, Melamed NV, Lebedeva CD, Sandakhchiev LS. Loktev VB, et al. Among authors: karpenko li. J Biotechnol. 1996 Jan 26;44(1-3):129-37. doi: 10.1016/0168-1656(95)00089-5. J Biotechnol. 1996. PMID: 8717396

4

Localization of the amino terminus of the hepatitis B virus core antigen within the core particle.

Karpenko LI, Ryazankin IA, Chikaev NA, Kolesnikova LV, Ilyichev AA. Karpenko LI, et al. Virus Res. 1997 Nov;52(1):15-23. doi: 10.1016/s0168-1702(97)00103-2. Virus Res. 1997. PMID: 9453141

5

[Design of virus-like particles, exposing HIV-1 epitopes].

Lebedev LR, Karpenko LI, Poryvaeva VA, Azaev MSh, Riabchikova EI, Gileva IP, Il'ichev AA. Lebedev LR, et al. Among authors: karpenko li. Mol Biol (Mosk). 2000 May-Jun;34(3):480-5. Mol Biol (Mosk). 2000. PMID: 10867928 Russian. No abstract available.

6

Insertion of foreign epitopes in HBcAg: how to make the chimeric particle assemble.

Karpenko LI, Ivanisenko VA, Pika IA, Chikaev NA, Eroshkin AM, Veremeiko TA, Ilyichev AA. Karpenko LI, et al. Amino Acids. 2000;18(4):329-37. doi: 10.1007/s007260070072. Amino Acids. 2000. PMID: 10949916

7

Construction of artificial virus-like particles exposing HIV epitopes, and the study of their immunogenic properties.

Karpenko LI, Lebedev LR, Ignatyev GM, Agafonov AP, Poryvaeva VA, Pronyaeva TR, Ryabchikova EI, Pokrovsky AG, Ilyichev AA. Karpenko LI, et al. Vaccine. 2003 Jan 17;21(5-6):386-92. doi: 10.1016/s0264-410x(02)00406-1. Vaccine. 2003. PMID: 12531636

8

[Artificial anti-HIV immunogens and methods of their delivery].

Karpenko LI, Bazhan SI, Ignat'ev GM, Lebedev LR, Il'ichev AA, Sandakhchiev LS. Karpenko LI, et al. Vestn Ross Akad Med Nauk. 2003;(1):24-30. Vestn Ross Akad Med Nauk. 2003. PMID: 12608081 Russian.

9

Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.

Bazhan SI, Belavin PA, Seregin SV, Danilyuk NK, Babkina IN, Karpenko LI, Nekrasova NA, Lebedev LR, Ignatyev GM, Agafonov AP, Poryvaeva VA, Aborneva IV, Ilyichev AA. Bazhan SI, et al. Among authors: karpenko li. Vaccine. 2004 Apr 16;22(13-14):1672-82. doi: 10.1016/j.vaccine.2003.09.048. Vaccine. 2004. PMID: 15068850

10

Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen.

Karpenko LI, Nekrasova NA, Ilyichev AA, Lebedev LR, Ignatyev GM, Agafonov AP, Zaitsev BN, Belavin PA, Seregin SV, Danilyuk NK, Babkina IN, Bazhan SI. Karpenko LI, et al. Vaccine. 2004 Apr 16;22(13-14):1692-9. doi: 10.1016/j.vaccine.2003.09.050. Vaccine. 2004. PMID: 15068852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page